AlphAIalphai — Financial news for AI agents
rttnews.comSEP 32 min read$CPB

Campbell's Sees Weak Results In FY27 As Slips To Loss In Q4; Slashes Dividend 36%; Stock Down 6.8%

Campbell Soup Co. (CPB) reported a Q4 net loss of $0.23 per share, down from $0.48 per share a year ago. The company expects FY27 adjusted earnings of $1.65-$1.80 per share, with net sales and organic net sales declining 4-2%. Campbell's cut its dividend by 36% and plans $500M in cost savings by 2030. Shares fell 6.81% in premarket trading.

Original reporting
rttnews.com
Published Sep 3, 2026, 12:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 1:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Campbell's Sees Weak Results In FY27 As Slips To Loss In Q4; Slashes Dividend 36%; Stock Down 6.8% — source image
Source · rttnews.com
Decision brief

The 30-second read

$CPBBearishHigh
01

Why it matters

The earnings miss and dividend cut are likely to trigger short‑term selling pressure, but the announced cost‑saving initiative could be a longer‑term upside catalyst.

02

Market read

The news provides fresh, material information that directly affects CPB's share price and may influence consumer‑staples sector sentiment.

03

What to watch

Cost‑saving program targeting $500 M by 2030 may mitigate margin erosion over the longer term.

Relevance 8/10Novelty 8/10Timing: pre‑market Thursday

Background

Campbell Soup (CPB) released its Q4 2026 results, showing a net loss and a reduced dividend, while providing FY27 guidance.

Company-level read

Ticker impact

$CPBBearishHigh confidence
Context

Campbell Soup reported a Q4 loss, cut its dividend 36% and gave FY27 guidance of $1.65‑$1.80 EPS, sending the stock down 6.8% pre‑market.

Expected impact

Further downside pressure likely if guidance holds; short‑term traders may target the 6‑8% drop.

Evidence & confidence

Guidance below expectations and a sizable dividend reduction are material catalysts that typically drive the stock lower.

Market effects

Sector

Consumer staples may face pressure as a major food‑product maker signals weaker demand.

Regional

U.S. market sentiment could dip slightly in the consumer staples segment.

Global

Limited; impact confined to U.S. equities and sector rotation.

Counterpoint

What could challenge this read

If the dividend cut improves cash flow, the stock could rebound on a valuation basis.

Key entities

  • company
    Campbell Soup Company

    U.S. packaged foods producer reporting Q4 loss and FY27 guidance.

  • executive
    Mick Beekhuizen

    President and CEO of Campbell Soup, quoted on the results.

Read at source← All news

Also covered by

1 outlet

Related articles

SEP 3
$CPBMedAI 8/10

Campbell's Q4 Earnings Call Highlights

Campbell Soup Company (CPB) reported Q4 results, highlighting 5% growth in semi-scratch cooking, led by Swanson, Pacific, and Rao's. U.S. soup consumption rose 0.9%, with premium brands Pacific and Rao's growing 14% and 25.3%, respectively. Snacks division faced pressure, with organic net sales declining 6%. The company plans cost savings, a dividend reset, and expects fiscal 2027 net sales to decline 2-4%.

yahoo.com2 min
SEP 3
$CPBHighAI 8/10

Campbell's forecasts weak year ahead on pressured consumer spending

Campbell Soup Company (CPB) forecasted weaker-than-expected annual profit and sales, citing soft demand for pricier snacks. The company cut its quarterly dividend by over a third and announced cost-saving measures, including plant closures and workforce reductions. CEO Mick Beekhuizen acknowledged unsatisfactory results and plans to adjust prices to reflect commodity cost changes. Analysts noted the company's aggressive self-help stance. Lower-income consumers are shifting to cheaper alternative

aol.com2 min
SEP 3
$SNOWMed

Stocks making the biggest moves premarket: Snowflake, Moderna, Broadcom & more

Snowflake shares surged 24% after Q2 results beat estimates, with revenue of $1.55B and EPS of $0.62. Broadcom fell 2.5% on lower Q4 revenue forecasts. Campbell's dropped 7% on weak fiscal 2027 guidance. Ultragenyx plunged 46% after a failed drug trial. Petco rose 9% on strong Q2 margins. Moderna declined 2% after a downgrade. Argan gained 7.5% on better-than-expected earnings. Five Below rose 4.5% on strong Q2 results. Victoria's Secret fell 18% on missed revenue estimates. Netskope rose 12% on

cnbc.com3 min
SEP 3
$CPBMedAI 8/10

Campbell’s forecasts annual sales below estimates on weak consumer spending

Campbell Soup Company (CPB) issued annual forecasts below estimates, citing weak demand for higher-priced products. The company expects fiscal 2027 net sales to fall 2-4%, below analysts' estimate of a 0.8% drop. Q4 net sales declined 8% to $2.1B. CPB cut its quarterly dividend by over a third to 25 cents and aims for $500M in cost savings by 2030. Adjusted profit per share is forecast at $2.17, above analysts' estimate of $1.86.

investing.com2 min